BA
The Boeing Company
BA offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
CNM
Core & Main, Inc.
CNM has the edge over BA overall, supported by stronger valuation and stronger modeled upside.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
CNM Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Stable |
CNM's profitability and cash flow are currently healthy, and its revenue and balance sheet are stable.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA has the edge over CNM in the historical PE scenario, which offers more potential upside but is not a forecast.
CNM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 14x | $44.62 | — |
| Cheap | 16x | $39.56 | -11% |
| Current | 18x | $44.62 | — |
| Fair | 22x | $54.21 | +21% |
| Expensive | 27x | $65.05 | +46% |
Historical ranges are pointers, not guarantees.
CNM's PE is in its cheap range at 18x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
BA has the edge over CNM on the outlook, with more favorable revenue expectations.
CNM Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| High |
Analysts expect CNM's earnings to grow and its profitability to improve, with its revenue holding steady.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has returned to profit: it earned $9.66 per share over the past year, after losing money the year before.
CNM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.29 | +36% |
| Q3 2026 | $2.43 | +8% |
| Q2 2026 | $2.36 | +9.3% |
| Q1 2026 | $2.31 | +8.5% |
| Q4 2025 | $2.28 | +7% |
| Q3 2025 | $2.25 | +7.7% |
| Q2 2025 | $2.16 | +0.9% |
| Q1 2025 | $2.13 | -0.9% |
| Q4 2024 | $2.13 | +0.5% |
CNM has the edge over BA on earnings, with more consistent year-over-year improvement.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA has the edge over CNM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA's operating margin was 1.5% last quarter, up 22 points from the same quarter a year ago.
CNM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.1B | +2.5% |
| Q2 2026 | $1.9B | -0.1% |
| Q1 2026 | $1.6B | -6.9% |
| Q4 2025 | $2.1B | +1.2% |
| Q3 2025 | $2.1B | +6.6% |
| Q2 2025 | $1.9B | +9.8% |
| Q1 2025 | $1.7B | +18% |
| Q4 2024 | $2B | +12% |
CNM's revenue grew through 2024 and has held roughly level since: $2.1B last quarter, up 2.5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | +0.4 points |
| Q2 2026 | 9.3% | +0.3 points |
| Q1 2026 | 7.5% | +0.2 points |
| Q4 2025 | 11% | -0.3 points |
| Q3 2025 | 10% | -0.2 points |
| Q2 2025 | 8.9% | -0.7 points |
| Q1 2025 | 7.3% | -0.8 points |
| Q4 2024 | 11% | -0.9 points |
CNM has the edge over BA on profitability, with a higher operating margin.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over CNM on cash flow, with more consistent year-over-year improvement.
CNM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $44M | +83% |
| Q2 2026 | $68M | +6.3% |
| Q1 2026 | $253M | +13% |
| Q4 2025 | $263M | +4.4% |
| Q3 2025 | $24M | -38% |
| Q2 2025 | $64M | -9.9% |
| Q1 2025 | $224M | -22% |
| Q4 2024 | $252M | -29% |
CNM still generates free cash flow, though less than at its 2023 peak: $628M over the past year.
BA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +2.1M shares |
| 1 year | +4.3% | +32.8M shares |
| 3 years | +31% | +186M shares |
| 5 years | +35% | +204M shares |
| Available history | +40% | +227M shares |
BA has 793M diluted shares, up 4.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
CNM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.2% | -2.3M shares |
| 1 year | -2.5% | -4.9M shares |
| 3 years | -16% | -35.6M shares |
| 5 years | +39% | +54.4M shares |
| Available history | +21% | +33.3M shares |
CNM has the edge over BA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $169M |
| Q2 2026 | $88M |
| Q1 2026 | $58M |
| Q4 2025 | $50M |
| Q3 2025 | $8M |
| Q2 2025 | $39M |
| Q1 2025 | $55M |
| Q4 2024 | $100M |
CNM spent $365M buying back its own shares over the past year, up 81% from the year before.
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
CNM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.3x | Moderate |
| Q2 2026 | 2.2x | Moderate |
| Q1 2026 | 2.1x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 2.4x | Moderate |
| Q2 2025 | 2.5x | Moderate |
| Q1 2025 | 2.5x | Moderate |
| Q4 2024 | 2.7x | Moderate |
CNM has the edge over BA on leverage, with a lower net debt burden relative to earnings.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
CNM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.6 | Neutral |
| Stochastic | 58.7 | Neutral |
CNM's weekly RSI is 49 (neutral) and its Stochastic is 59 (neutral).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA has the edge over CNM on valuation relative to its sector.
CNM PE vs Industrials Sector
| Metric | CNM | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 24% below |
| PE % | 23 | 63 | 40 pts below |
CNM is trading at 18x earnings, a 24% discount to the Industrials sector's median of 24x.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
CNM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $42.9 | 4% above |
| 20 week MA | $43.7 | 2% above |
| 50 week MA | $48.6 | 8.2% below |
| 100 week MA | $51.5 | 13% below |
| 200 week MA | $45.2 | 1.4% below |
CNM has the edge over BA on trend strength, trading above more of its moving averages.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has finished lower in four of the last six years. It's down 21% so far in 2026.
CNM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $23.7 | $29.5 | +25% |
| 2022 | $29.5 | $19.2 | -35% |
| 2023 | $19.2 | $40.4 | +111% |
| 2024 | $40.4 | $51.0 | +26% |
| 2025 | $51.0 | $54.0 | +5.8% |
| 2026 YTD | $54.0 | $44.6 | -17% |
CNM has the edge over BA on returns for 2026, with the stronger performance.